Search Results

You are looking at 1 - 2 of 2 items for :

  • By Author: Spetzler, Robert F. x
  • By Author: Babu, Ranjith x
Clear All
Full access

based on the paired t-test). Results Fifteen patients were treated with a single administration of NuQu juvenile chondrocytes. Levels: L3-4=2, L4-5=1, L5-S1=12. Pfirrman grade III=12; grade IV=3. Each treatment consisted of 1–2 cc (mean volume=1.3cc) of juvenile chondrocytes (~ 10 million cells/ml) with fibrin glue carrier. Mean peak pressure= 87.6 psi. Twelve patients (80%) were available for 2-year follow-up. The mean ODI (baseline=53; 24 months=14.3; p<0.0001), NRS (baseline=5.7; 24 months=2.5; p=0.0036) and SF-36 Physical scores (baseline=35.3; 24 months=49

Free access

some patients showed viral protein, DNA, and RNA including CD, but with viral genes only detected in limited amounts and not in all samples (up to 2000 DNA copies/μg tissue). MRI immediately after injecting Toca 511 plus gadolinium showed imprecise delivery. Therefore, realtime MRI-guided CED was implemented. In 7 patients at a single center (average tumor volume = 10.5 cm3, range=2.6–25.0 cm3) 12–70% of tumor volume (mean=45%) was infused. A 14-gauge cannula allowed flow rates up to 50 microL/min without reflux, and 3.1 mL was delivered to 1–3 targets with improved